A Mexican-made vaccine that reduces the risks of complications from Covid-19 has been approved by the nation’s health regulator, the Commission for Protection against Health Risks (Cofepris), President Andrés Manuel López Obrador announced this week.
The Patria vaccine has arrived on the scene exactly four years after nations around the world began to close their borders and limit activities when the SARS-CoV-2 virus spread quickly around the globe.
Originally, federal authorities had planned for the introduction of the Mexican vaccine by the end of 2021. A shortage of volunteers for clinical trials has been put forward as an explanation for the delay.
The vaccine was spearheaded by the National Council of Humanities, Sciences and Technologies (Conahcyt), together with Avi-Mex, a company that specializes in the manufacture of vaccines for animals, and collaboration from universities and other public institutions such as the Mexican Social Security Institute (IMSS).